ABACAVIR AND LAMIVUDINE
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for ABACAVIR AND LAMIVUDINE, covering 2015-12-22 to 2025-04-16. Get the full timeline:
Most recent: FDA Approved: ABACAVIR AND LAMIVUDINE — Original Application (Camber Pharmaceuticals, Inc.)